Brown E M, Gardner J D, Aurbach G D
Endocrinology. 1976 Nov;99(5):1370-6. doi: 10.1210/endo-99-5-1370.
Previous studies on the interaction of labeled beta-adrenergic blockers with beta-adrenergic receptors have employed broken cell or membrane preparations. We have now carried out direct binding analysis on intact turkey erythrocytes employing the potent, high specific activity blocker [125I]-hydroxbenzylpindolol (HYP). [125I]HYP binds to a single class of receptor sites with a K of 5.3 X 10(10)M-1 and a binding capacity of 400-500 sites/cell. These results as well as the kinetics of association and dissociation and lack of evidence for negative cooperativity all agree well with studies reported earlier on membrane preparations from the same cells. True dissociation constants (Kd) for agonists and antagonists determined by inhibition of binding of [125I]HYP are in good agreement with results in membrane preparations. These Kd's have been compared directly with activation or inhibition constants for effects on adenylate cyclase using generation of [14C]cAMP from [14C]adenine in intact cells. The close correlation between effects on binding and adenylate cyclase activity in whole cells are similar to results obtained in membrane preparations in the presence of guanine nucleotides, suggesting the presence of an analogous regulatory substance in vivo.
以往关于标记的β-肾上腺素能阻滞剂与β-肾上腺素能受体相互作用的研究采用的是破碎细胞或细胞膜制剂。我们现在使用强效、高比活性的阻滞剂[125I]-羟基苄基吲哚洛尔(HYP)对完整的火鸡红细胞进行了直接结合分析。[125I]HYP与一类受体位点结合,其解离常数K为5.3×10(10)M-1,结合容量为400 - 500个位点/细胞。这些结果以及结合和解离动力学以及缺乏负协同性的证据均与早期关于来自相同细胞的细胞膜制剂的研究结果非常吻合。通过抑制[125I]HYP的结合所测定的激动剂和拮抗剂的真实解离常数(Kd)与细胞膜制剂中的结果高度一致。这些Kd已与使用完整细胞中[14C]腺嘌呤生成[14C]环磷酸腺苷(cAMP)来测定的对腺苷酸环化酶作用的激活或抑制常数直接进行了比较。对全细胞中结合和腺苷酸环化酶活性的影响之间的密切相关性类似于在存在鸟嘌呤核苷酸的情况下在细胞膜制剂中获得的结果,这表明体内存在一种类似的调节物质。